BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:With Adicet Bio\, In8Bio\, Gamma Delta Therapeutics\, Lava The
 rapeutics\, and ImCheck Therapeutics releasing clinical data from enginee
 red and antibody-based γδT Therapy in patients\; the race to market for t
 he first allogeneic and solid tumor-targeting γδT Therapy is truly on.\n\
 nJoin the 3rd Gamma Delta T Therapies Summit to learn and network with 12
 0+ of the world's leaders including γδT pioneer\, Adrian Hayday\, and tog
 ether accelerate the development of effective\, persistent\, globally acc
 essible cell therapy for solid tumors.\n\nEnhance cytotoxicity\, discover
  novel targets\, engineer stealth and persistence\, interrogate cell subs
 ets\, and scale-up manufacturing through a deep understanding of the fund
 amental biology and target product profile for γδT therapies.\n\nIndustry
  experts agree that this year\, the γδT is the cell to know. Ensure you a
 nd your team are ahead of the curve and equipped with the need-to-know in
 sights to advance successful therapeutics\, across 2 dedicated tracks cov
 ering Discovery\, Process Research\, Preclinical\, and Clinical Developme
 nt\; as well as 3 deep-dive workshops\, and a Gamma Delta 101 Bootcamp.\n
DTEND:20220728T174500
DTSTAMP:20260512T232256Z
DTSTART:20220726T083000
LOCATION:120\, Huntington Avenue\, Boston\, Massachusetts\, 02116\,
SEQUENCE:0
SUMMARY:With Adicet Bio\, In8Bio\, Gamma Delta Therapeutics\, Lava Therape
 utics\, and ImCheck Therapeutics releasing clinical data from engineered 
 and antibody...
UID:99204f79-7648-49bb-9f4b-08c8cc5d6544
END:VEVENT
END:VCALENDAR